Robert Weinkove, MD

Wellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, New Zealand; Malaghan Institute of Medical Research, New Zealand

n/a

Poster(s):

• 2017 - Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized CLL14 study